Christopher C. Sappenfield

MH2 Technology Law Group, LLP (USA)

Chris Sappenfield has substantial experience handling diverse world-wide intellectual property law-related matters in both law firm and in-house corporate settings with an emphasis in the technical areas of bioinformatics, artificial intelligence, molecular diagnostics, pharmaceuticals, medical devices, and complex healthcare-related systems. Mr. Sappenfield handles all aspects of patent law and possesses significant depth of knowledge and experience in assessing the commercial potential of new technologies, and in designing and implementing complex patent portfolio strategies that emphasize obtaining high value investment-grade patents.

Before joining MH2 Technology Law Group, LLP, Mr. Sappenfield worked in start-up environments as well as in the settings of premier global enterprises, including Hoffman La Roche and Abbott Laboratories.

In addition to his formal legal training, Mr. Sappenfield also received an M.Sc. in Bioinformatics from Oxford University; an M.A. in Biochemistry from the University of Denver; and a Certificate in Data Science and Machine Learning: Making Data-Driven Decisions, Massachusetts Institute of Technology.